Current Share Price: 12.070
Bonitas Research
Initial Report Date（2023/02/22）Share Price:16.960
Initial Report Date（2023/02/22）Share Price:16.960
HARROW HEALTH – $HROW – LATEST IDEA – FEBRUARY 22, 2023
Details Link > Harrow burns cash from operations and relies on external financing for survival. We think Harrow did not disclose to investors the existence of a DOJ investigation because it would have compromised Harrow’s ability to raise capital. With significant liabilities managed by bad actors willing to enrich themselves at the expense of minority Harrow shareholders, we are short Harrow and think its stock is going lower.
By wantattse
